Tcc denied due to quantity / dose limits by Humana?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Humana typically requires
Humana's specific coverage criteria for tcc are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Humana angle on Tcc
## Why Humana Applies Quantity Limits to Total Contact Casting — and How to Appeal
Humana's wound-care coverage policy includes application-frequency and total-application limits for total contact casting (TCC). These limits reflect a general expectation about the treatment course for a typical patient. When a patient requires more frequent changes (due to exudate level, wound deterioration, infection risk, or cast intolerance) or a longer treatment course (for a wound that is healing but not yet closed), claims beyond those limits are denied as exceeding quantity limits. This type of denial is among the most consistently overturnable on appeal when the clinical record supports the ongoing need.
## Why This Denial Is Appealable
Quantity limits are not hard clinical maximums — they are administrative utilization thresholds that the insurer must be willing to override when the treating provider documents continued medical necessity. Humana's own policy, and the Medicare LCD framework on which it is modeled, recognizes that some wounds require extended treatment courses. The key is documenting that the wound is still actively healing (not stagnant/healed) and that continued TCC application is the clinically indicated intervention to reach closure.
## Federal Appeal Framework
- Internal appeal: File within 180 days. Include updated wound photography and a healing-progress note from the most recent visits.
- Expedited appeal: If denial of continued TCC poses risk of wound deterioration or amputation, request expedited review (72-hour turnaround).
- Peer-to-peer review: Request between Humana's reviewing clinician and the treating wound-care provider to present the healing trajectory and explain why additional applications are medically necessary.
- External review (ACA §2719 / ERISA §503): After adverse internal decision, file for external review within the ~4-month window. Independent reviewers focus on clinical necessity, not administrative limits.
## Documentation to Gather
1. Serial wound measurement records: Dated wound photographs and measurement logs showing wound-area reduction over the treatment course (e.g., from the wound-care EHR or wound-care system). 2. Healing-trajectory progress notes: Treating clinician's notes at each visit documenting wound status, depth change, exudate, and whether the wound is actively progressing toward closure. 3. Reason for extended course: Documentation of any clinical factors that slowed healing (infection episode, patient comorbidities, adherence period, wound size at baseline). 4. Prescriber letter for continued necessity: A wound-care-credentialed provider's written explanation of why additional TCC applications are clinically necessary to achieve wound closure and avoid limb-threatening consequences. 5. Wound-closure goal: A documented clinical plan — how many additional applications are anticipated and why.
## Criteria-Mapping Structure
Obtain Humana's wound-care medical coverage policy (and the CMS Wound Care LCD it references) and map the continued-necessity criteria:
| Continued-Necessity Criterion | Supporting Documentation | |---|---| | Wound is still open (not healed) | Most recent wound measurement + photo | | Wound is actively healing (not stagnant) | Serial measurement log showing area reduction | | No change in indication (neuropathy + no severe ischemia/infection) | Current clinical exam note | | No alternative treatment is superior | Prescriber letter explaining TCC continues to be the appropriate modality | | Treating provider is credentialed | Credential certificate on file |
A wound-care-credentialed provider's peer-to-peer with Humana's medical reviewer, armed with wound photography and serial measurements, is the single most effective way to overturn a quantity-limit denial for TCC.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →